Clinical Trial Update: A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the 24-hour antihypertensive efficacy of Fimasartan in adults with mild-to-moderate essential hypertension. The study has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2018-02-13